Follow-on biologics: background and issues
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
New York, NY
Nova Science
2011
|
| Schriftenreihe: | Biotechnology in agriculture, industry and medicine
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | Includes bibliographical references and index FDA regulation of follow-on biologics / Judith A. Johnson -- P.l. 111-148 : intellectual property provisions for follow-on biologics / Wendy H. Schacht, John R. Thomas -- Follow-on biologics : intellectual property and innovation issues / Wendy H. Schacht, John R. Thomas -- Emerging health care issues : follow-on biologic drug competition (Federal Trade Commission report) |
| Beschreibung: | VIII, 148 S. |
| ISBN: | 9781611220766 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV037413559 | ||
| 003 | DE-604 | ||
| 005 | 20111202 | ||
| 007 | t | ||
| 008 | 110523s2011 |||| 00||| eng d | ||
| 010 | |a 2010041309 | ||
| 020 | |a 9781611220766 |c hardcover |9 978-1-61122-076-6 | ||
| 035 | |a (DE-599)GBV636653315 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-M382 | ||
| 245 | 1 | 0 | |a Follow-on biologics |b background and issues |c Daniel J. Gutiérrez, ed. |
| 264 | 1 | |a New York, NY |b Nova Science |c 2011 | |
| 300 | |a VIII, 148 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Biotechnology in agriculture, industry and medicine | |
| 500 | |a Includes bibliographical references and index | ||
| 500 | |a FDA regulation of follow-on biologics / Judith A. Johnson -- P.l. 111-148 : intellectual property provisions for follow-on biologics / Wendy H. Schacht, John R. Thomas -- Follow-on biologics : intellectual property and innovation issues / Wendy H. Schacht, John R. Thomas -- Emerging health care issues : follow-on biologic drug competition (Federal Trade Commission report) | ||
| 650 | 4 | |a Pharmaceutical biotechnology | |
| 650 | 4 | |a Pharmaceutical biotechnology / Law and legislation / United States | |
| 650 | 4 | |a Biological Products / standards / United States | |
| 650 | 4 | |a Drug Approval / United States | |
| 650 | 4 | |a Patents as Topic / United States | |
| 650 | 4 | |a Recht | |
| 651 | 4 | |a USA | |
| 700 | 1 | |a Gutiérrez, Daniel J. |e Sonstige |4 oth | |
| 856 | 4 | |m DE-601 |q pdf/application |u http://www.gbv.de/dms/bs/toc/636653315.pdf |z kostenfrei |3 Inhaltsverzeichnis | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-022565972 | ||
Datensatz im Suchindex
| _version_ | 1804145711909961728 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV037413559 |
| ctrlnum | (DE-599)GBV636653315 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01694nam a2200385 c 4500</leader><controlfield tag="001">BV037413559</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20111202 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">110523s2011 |||| 00||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2010041309</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781611220766</subfield><subfield code="c">hardcover</subfield><subfield code="9">978-1-61122-076-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)GBV636653315</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-M382</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Follow-on biologics</subfield><subfield code="b">background and issues</subfield><subfield code="c">Daniel J. Gutiérrez, ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York, NY</subfield><subfield code="b">Nova Science</subfield><subfield code="c">2011</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">VIII, 148 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Biotechnology in agriculture, industry and medicine</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">FDA regulation of follow-on biologics / Judith A. Johnson -- P.l. 111-148 : intellectual property provisions for follow-on biologics / Wendy H. Schacht, John R. Thomas -- Follow-on biologics : intellectual property and innovation issues / Wendy H. Schacht, John R. Thomas -- Emerging health care issues : follow-on biologic drug competition (Federal Trade Commission report)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical biotechnology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical biotechnology / Law and legislation / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biological Products / standards / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Approval / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Patents as Topic / United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Recht</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gutiérrez, Daniel J.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2=" "><subfield code="m">DE-601</subfield><subfield code="q">pdf/application</subfield><subfield code="u">http://www.gbv.de/dms/bs/toc/636653315.pdf</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-022565972</subfield></datafield></record></collection> |
| geographic | USA |
| geographic_facet | USA |
| id | DE-604.BV037413559 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T23:23:48Z |
| institution | BVB |
| isbn | 9781611220766 |
| language | English |
| lccn | 2010041309 |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-022565972 |
| open_access_boolean | 1 |
| owner | DE-M382 |
| owner_facet | DE-M382 |
| physical | VIII, 148 S. |
| publishDate | 2011 |
| publishDateSearch | 2011 |
| publishDateSort | 2011 |
| publisher | Nova Science |
| record_format | marc |
| series2 | Biotechnology in agriculture, industry and medicine |
| spelling | Follow-on biologics background and issues Daniel J. Gutiérrez, ed. New York, NY Nova Science 2011 VIII, 148 S. txt rdacontent n rdamedia nc rdacarrier Biotechnology in agriculture, industry and medicine Includes bibliographical references and index FDA regulation of follow-on biologics / Judith A. Johnson -- P.l. 111-148 : intellectual property provisions for follow-on biologics / Wendy H. Schacht, John R. Thomas -- Follow-on biologics : intellectual property and innovation issues / Wendy H. Schacht, John R. Thomas -- Emerging health care issues : follow-on biologic drug competition (Federal Trade Commission report) Pharmaceutical biotechnology Pharmaceutical biotechnology / Law and legislation / United States Biological Products / standards / United States Drug Approval / United States Patents as Topic / United States Recht USA Gutiérrez, Daniel J. Sonstige oth DE-601 pdf/application http://www.gbv.de/dms/bs/toc/636653315.pdf kostenfrei Inhaltsverzeichnis |
| spellingShingle | Follow-on biologics background and issues Pharmaceutical biotechnology Pharmaceutical biotechnology / Law and legislation / United States Biological Products / standards / United States Drug Approval / United States Patents as Topic / United States Recht |
| title | Follow-on biologics background and issues |
| title_auth | Follow-on biologics background and issues |
| title_exact_search | Follow-on biologics background and issues |
| title_full | Follow-on biologics background and issues Daniel J. Gutiérrez, ed. |
| title_fullStr | Follow-on biologics background and issues Daniel J. Gutiérrez, ed. |
| title_full_unstemmed | Follow-on biologics background and issues Daniel J. Gutiérrez, ed. |
| title_short | Follow-on biologics |
| title_sort | follow on biologics background and issues |
| title_sub | background and issues |
| topic | Pharmaceutical biotechnology Pharmaceutical biotechnology / Law and legislation / United States Biological Products / standards / United States Drug Approval / United States Patents as Topic / United States Recht |
| topic_facet | Pharmaceutical biotechnology Pharmaceutical biotechnology / Law and legislation / United States Biological Products / standards / United States Drug Approval / United States Patents as Topic / United States Recht USA |
| url | http://www.gbv.de/dms/bs/toc/636653315.pdf |
| work_keys_str_mv | AT gutierrezdanielj followonbiologicsbackgroundandissues |